RetractedArticleBioengineered2021

MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel.

Jie Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.